AEON Biopharma
AEON
AEON
73 hedge funds and large institutions have $192M invested in AEON Biopharma in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+14
Holders Change %
+23.73%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
14
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$6.55M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$4.48M |
| 3 |
Millennium Management
New York
|
+$3.72M |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.66M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.49M |
